An Israeli company is helping doctors treat cancer by freezing tumors with liquid nitrogen.
IceCure Medical, a company based in Israel’s northern coastal city of Caesarea, claims its non-invasive ProSense™ system is a quick and painless alternative to cancer-removal surgery.
ProSense™ is FDA and CE approved and is available in the United States, Europe, Hong Kong, Thailand, Singapore, Central America and South America.
ProSense works by inserting an extremely thin probe directly into the tumor, injecting it with a -274 degrees Fahrenheit liquid nitrogen solution and freezing it. The solution destroys the tumor but leaves surrounding tissue unharmed. The body then absorbs the dead tumor. The treatment can take up to an hour, and the only pain medication needed is local anesthesia.
Many patients are even allowed to go home the day of the procedure.
“Treatment with our system enables the elimination of the entire tumor by freezing. Patients taking part in the trial can enjoy their routine lives after a brief and straightforward treatment, without scars and without changing the shape or size of the breast,” said IceCure Medical CEO Eyal Shamir.
This kind of treatment is called “cryotherapy,” and it has been used to treat the early stages of breast cancer and benign breast tumors known as Fibroadenoma (FA).
A 2012 study found that “cryodestruction proved functional and safe, while showing reduction in palpability and pain caused by the FA in the treated patients.”
Click here to read the rest of this story from our content partners at CBN News. {eoa}
See an error in this article?
To contact us or to submit an article
